<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="2481">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05128864</url>
  </required_header>
  <id_info>
    <org_study_id>HTO_fulkerson</org_study_id>
    <nct_id>NCT05128864</nct_id>
  </id_info>
  <brief_title>High Tibial Osteotomy With/Without Fulkerson Osteotomy in Knee OA</brief_title>
  <official_title>Prospective, Randomized, Double Blinded Trial Comparing Clinical, Radiological and Laboratory Outcomes of Hight Tibial Osteotomy With or Without Concomitant Fulkerson Osteotomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre of Postgraduate Medical Education</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre of Postgraduate Medical Education</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will compare Hight Tibial Osteotomy with or without Fulkerson Osteotomy performed&#xD;
      on patients with early stages of Osteoarthritis with patellofemoral joint disorders. The&#xD;
      purpose of this study is evaluate which type of osteotomy provides better clinical,&#xD;
      radiological and laboratory outcomes.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Progression of knee cartilage degenerative changes leads to necessary total knee arthroplasty&#xD;
      in future, which is the most popular procedure for treating OA. HTO applied at early stages&#xD;
      of osteoarthritis allow slow down cartilage degeneration process, but the choice of performed&#xD;
      surgery depends on surgeons personal assessment. Patellofemoral Pain Syndrome often occurs&#xD;
      with knee arthritis. Antero-medialisation of tibial tubercle is frequent procedures for&#xD;
      patella maltracking. So far, both, HTO and Fulkerson osteotomy was performed separately, even&#xD;
      if patient have symptoms from patellofemoral joint and OA. The investigators believe that&#xD;
      simultaneously surgery of HTO and fulkerson Osteotomy provides better outcomes and&#xD;
      significantly slow down knee degeneration.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2020</start_date>
  <completion_date type="Anticipated">May 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biomechanics MRI</measure>
    <time_frame>1 year</time_frame>
    <description>Patellofemoral Joints Biomechanics improvement measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomechanics MRI</measure>
    <time_frame>2 years</time_frame>
    <description>Patellofemoral Joints Biomechanics improvement measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomechanics X-ray</measure>
    <time_frame>12 weeks</time_frame>
    <description>Patellofemoral Joints Biomechanics improvement measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomechanics X-ray</measure>
    <time_frame>6 months</time_frame>
    <description>Patellofemoral Joints Biomechanics improvement measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomechanics X-ray</measure>
    <time_frame>12 months</time_frame>
    <description>Patellofemoral Joints Biomechanics improvement measured</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Biomechanics X-ray</measure>
    <time_frame>24 months</time_frame>
    <description>Patellofemoral Joints Biomechanics improvement measured</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>KOOS</measure>
    <time_frame>12 weeks</time_frame>
    <description>Knee Injury and Osteoarthritis Outcome Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>KOOS</measure>
    <time_frame>6 months</time_frame>
    <description>Knee Injury and Osteoarthritis Outcome Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>KOOS</measure>
    <time_frame>12 months</time_frame>
    <description>Knee Injury and Osteoarthritis Outcome Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>KOOS</measure>
    <time_frame>24 months</time_frame>
    <description>Knee Injury and Osteoarthritis Outcome Score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IKDC</measure>
    <time_frame>12 weeks</time_frame>
    <description>International Knee Documentation Committee</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IKDC</measure>
    <time_frame>6 months</time_frame>
    <description>International Knee Documentation Committee</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IKDC</measure>
    <time_frame>12 months,</time_frame>
    <description>International Knee Documentation Committee</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>IKDC</measure>
    <time_frame>24 months</time_frame>
    <description>International Knee Documentation Committee</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tegner Lysholm</measure>
    <time_frame>12 weeks,</time_frame>
    <description>Tegner Lysholm Knee Scoring Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tegner Lysholm</measure>
    <time_frame>6 months</time_frame>
    <description>Tegner Lysholm Knee Scoring Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tegner Lysholm</measure>
    <time_frame>12 months</time_frame>
    <description>Tegner Lysholm Knee Scoring Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tegner Lysholm</measure>
    <time_frame>24 months</time_frame>
    <description>Tegner Lysholm Knee Scoring Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36</measure>
    <time_frame>12 weeks</time_frame>
    <description>The Short Form (36) Health Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36</measure>
    <time_frame>6 months</time_frame>
    <description>The Short Form (36) Health Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36</measure>
    <time_frame>12 months</time_frame>
    <description>The Short Form (36) Health Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SF-36</measure>
    <time_frame>24 months</time_frame>
    <description>The Short Form (36) Health Survey</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS</measure>
    <time_frame>12 week</time_frame>
    <description>Pain Visual Analog Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS</measure>
    <time_frame>6 months</time_frame>
    <description>Pain Visual Analog Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS</measure>
    <time_frame>12 months</time_frame>
    <description>Pain Visual Analog Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VAS</measure>
    <time_frame>24 months</time_frame>
    <description>Pain Visual Analog Scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood test</measure>
    <time_frame>2nd day</time_frame>
    <description>CRP, IL-6, CTx</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood test</measure>
    <time_frame>6 weeks</time_frame>
    <description>CRP, IL-6, CTx</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">110</enrollment>
  <condition>Osteoarthritis, Knee</condition>
  <condition>Patellofemoral Disorder</condition>
  <arm_group>
    <arm_group_label>HTO and Fulkerson</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>High Tibial Osteotomy with Antero-medialisation of Tibial Tubercle</description>
  </arm_group>
  <arm_group>
    <arm_group_label>HTO</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Descending Hight Tibial Osteotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>High Tibial Osteotomy</intervention_name>
    <description>Surgery procedure - High Tibial Osteotomy</description>
    <arm_group_label>HTO</arm_group_label>
    <arm_group_label>HTO and Fulkerson</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Knee medial compartment or patellofemoral osteoarthritis in medical interview and&#xD;
             physical examination&#xD;
&#xD;
          -  Confirmation of cartilage degeneration/damage and knee malalignment in radiological&#xD;
             tests&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no informed consent to participate in the study&#xD;
&#xD;
          -  age under 18 years or above 65&#xD;
&#xD;
          -  multi ligament injury or single plane knee instability&#xD;
&#xD;
          -  another musculoskeletal disorders in lower limb&#xD;
&#xD;
          -  lower limb deformity requiring axis correction below 4o or above 12.5o&#xD;
&#xD;
          -  joints inflammatory diseases&#xD;
&#xD;
          -  ASA score &gt; II&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rafal Kaminski</last_name>
    <role>Principal Investigator</role>
    <affiliation>PCME, Otwock, Poland</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Rafał Kamiński, MD PhD</last_name>
    <phone>+48227794031</phone>
    <phone_ext>469</phone_ext>
    <email>kaminski@spskgruca.pl</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Orthopaedics and Traumatology, Postgraduate Center for Medical Education, Professor A. Gruca Teaching Hospital</name>
      <address>
        <city>Otwock</city>
        <state>Mazowieckie</state>
        <zip>05-400</zip>
        <country>Poland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rafal Kaminski, MD PhD</last_name>
      <phone>+48227794031</phone>
      <phone_ext>431</phone_ext>
      <email>rkaminski@spskgruca.pl</email>
    </contact>
    <contact_backup>
      <last_name>Stanislaw Pomianowski, MD PhD Prof</last_name>
      <phone>+48227794031</phone>
      <phone_ext>481</phone_ext>
      <email>spom@spskgruca.pl</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Poland</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>July 18, 2020</study_first_submitted>
  <study_first_submitted_qc>November 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 22, 2021</study_first_posted>
  <last_update_submitted>November 9, 2021</last_update_submitted>
  <last_update_submitted_qc>November 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre of Postgraduate Medical Education</investigator_affiliation>
    <investigator_full_name>Rafał Kamiński</investigator_full_name>
    <investigator_title>Chair of Division</investigator_title>
  </responsible_party>
  <keyword>HTO</keyword>
  <keyword>Fulkerson</keyword>
  <keyword>Osteoarthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Osteoarthritis, Knee</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

